ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meetings
    • ACR Convergence 2024
    • ACR Convergence 2023
    • 2023 ACR/ARP PRSYM
    • ACR Convergence 2022
    • ACR Convergence 2021
    • ACR Convergence 2020
    • 2020 ACR/ARP PRSYM
    • 2019 ACR/ARP Annual Meeting
    • 2018-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • ACR Meetings

Abstracts tagged "citrullination and rheumatoid arthritis"

  • Abstract Number: 570 • 2016 ACR/ARHP Annual Meeting

    A Molecular Timeline for Preclinical RA Pathogenesis Defined By Dysregulated PTPN22, Hypercitrullination, and Aberrant Cytokine/Metabolic Profiles in PBMC of at-Risk Individuals

    Hui-Hsin Chang1, Nishant Dwivedi2, Bo Sun2, Deepak A. Rao3, Jeffrey A. Sparks3, Jennifer Kinslow4, Yuko Okamoto4, Kevin D. Deane5, M. Kristen Demoruelle6, Jill M. Norris7, Elizabeth Karlson2, V. Michael Holers8 and I-Cheng Ho1, 1Brigham and Women's Hospital, Harvard Medical School, Boston, MA, 2Medicine, Brigham and Women's Hospital, Harvard Medical School, Boston, MA, 3Division of Rheumatology, Immunology, and Allergy, Brigham and Women's Hospital, Harvard Medical School, Boston, MA, 4University of Colorado School of Medicine, Aurora, CO, 5Division of Rheumatology, University of Colorado School of Medicine, Aurora, CO, 6Rheumatology, University of Colorado School of Medicine, Aurora, CO, 7Epidemiology, Colorado School of Public Health, Aurora, CO, 8Rheumatology Division, University of Colorado School of Medicine, Aurora, CO

    Background/Purpose: One unique feature of RA is the presence of ACPA. PTPN22 is a phosphatase that also acts to suppress citrullination independently of its phosphatase…
  • Abstract Number: 2417 • 2013 ACR/ARHP Annual Meeting

    Antibodies To Porphyromonas Gingivalis Peptidylarginine Deiminase In Rheumatoid Arthritis Are Not Directed Against The Autocitrullinated Enzyme

    Maximilian F. Konig1, Alizay Paracha2, Malini Moni1, Clifton O. Bingham III1 and Felipe Andrade1, 1Division of Rheumatology, Division of Rheumatology, Johns Hopkins University School of Medicine, Baltimore, MD, 2The University of Oklahoma, Norman, OK

    Background/Purpose: Porphyromonas gingivalis (Pg) has received considerable attention by investigators trying to explain the striking association of periodontal disease (PD) and rheumatoid arthritis (RA). Bacterial…
  • Abstract Number: 2233 • 2013 ACR/ARHP Annual Meeting

    Porphyromonas Gingivalis peptidylarginine Deiminase Exacerbates Collagen-Induced Arthritis In C57BL/6 mice 

    Saba Alzabin1,2, Anne-Marie Quirke2, Elena B. Lugli2, Muslima Choudhury2,3, Peter J. Charles4, Richard O. Williams5 and Patrick Venables6, 1Epistem Ltd., Manchester, United Kingdom, 2University of Oxford, Kennedy Institute of Rheumatology, Oxford, United Kingdom, 3Kennedy Institute of Rheumatology, London, United Kingdom, 4Oxford University, Kennedy Institute of Rheumatology, Oxford, United Kingdom, 5Kennedy Institute of Rheumatology, Oxford University, Oxford, United Kingdom, 6Kennedy Institute of Rheumatology, Oxford, United Kingdom

    Background/Purpose: There is increasing molecular and epidemiological evidence linking Porphyromonas gingivalis to RA. P. gingivalis is unique amongst periodontal pathogens in possessing a citrullinating enzyme…
Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM ET on November 14, 2024. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].

Wiley

  • Online Journal
  • Privacy Policy
  • Permissions Policies
  • Cookie Preferences

© Copyright 2025 American College of Rheumatology